Familial Aggregation of Irritable Bowel Syndrome: A Family Case-Control Study

被引:81
|
作者
Saito, Yuri A. [1 ]
Petersen, Gloria M. [2 ]
Larson, Joseph J. [3 ]
Atkinson, Elizabeth J. [3 ]
Fridley, Brooke L. [3 ]
de Andrade, Mariza [3 ]
Locke, G. Richard, III
Zimmerman, Janice M.
Almazar-Elder, Ann E.
Talley, Nicholas J.
机构
[1] Mayo Clin, Miles & Shirley Fiterman Ctr Digest Dis, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA
[2] Mayo Clin, Div Epidemiol, Rochester, MN 55905 USA
[3] Mayo Clin, Div Biostat, Rochester, MN 55905 USA
来源
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2010年 / 105卷 / 04期
基金
美国国家卫生研究院;
关键词
QUALITY-OF-LIFE; VALIDATION; EPIDEMIOLOGY; GENETICS; TWINS;
D O I
10.1038/ajg.2010.116
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
OBJECTIVES: Irritable bowel syndrome (IBS) clusters in families, but previous studies documented family history only from patients. We have shown that patient-relative agreement on IBS status is poor. Thus, we conducted a family case-control study with direct survey of symptoms from family members to better quantitate the aggregation of IBS in families. The aims of this study were to (i) compare the prevalence of IBS in case-relatives with control-relatives, and (ii) determine whether gender, relationship, predominant symptom, and environmental risk factors affect familial aggregation. METHODS: Outpatients with IBS, matched controls, and their first-degree relatives completed a bowel symptom questionnaire. Percent of cases and controls with a family history were compared and odds ratios were computed using chi(2)-test; recurrence risks to relatives were computed using logistic regression and generalized estimating equations. RESULTS: Data were collected from 477 cases, 297 controls, 1,492 case-relatives, and 936 control-relatives. Probands had a median age of 50 and 78% were women. 50% of case and 27% of control families had at least another relative with IBS yielding an odds ratio of 2.75 (95% CI: 2.01-3.76, P < 0.0001). When aggregation estimates were reevaluated stratifying by relative relationship or proband gender, generational and gender effects were not observed. Familial clustering by bowel habit was weakest for diarrhea, and strongest for alternating bowel habits. CONCLUSIONS: IBS aggregates strongly in families. The strength of the association does vary somewhat by relationship to proband, but the lack of association in spouses supports either a possible genetic etiology or a shared household environmental exposure as an underlying cause of IBS.
引用
收藏
页码:833 / 841
页数:9
相关论文
共 50 条
  • [41] A population-based case-control proband study on familial aggregation of metabolic syndrome in Taiwan
    Lin, WY
    Chen, HH
    Lin, RS
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 2004, 28 : S63 - S63
  • [42] Small intestinal bacterial overgrowth in a children population affected by irritable bowel syndrome: a case-control study
    Scarpellini, E.
    Fundaro, C.
    Giorgio, V.
    Pantanella, A.
    Cesario, V.
    Roccarina, D.
    Lauritano, E. C.
    Sparano, L.
    Novi, M. L.
    Ainora, M.
    Garcovich, M.
    Fiore, F.
    Cammarota, G.
    Gasbarrini, G.
    Ghirlanda, G.
    Gasbarrini, A.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2009, 13 : 99 - 99
  • [43] Factors affecting the use of herbal products in patients with Irritable Bowel Syndrome and their results: case-control study
    Gemcioglu, Emin
    Cakmak, Nuray Yilmaz
    Baser, Salih
    Kocaoz, Servet
    Ersoy, Osman
    [J]. BMC GASTROENTEROLOGY, 2022, 22 (01)
  • [44] Small intestinal bacterial overgrowth in a children population affected by irritable bowel syndrome: A case-control study
    Scarpellini, E.
    Fundaro, C.
    Giorgio, V.
    Pantanella, A.
    Cesario, V.
    Lauritano, Ernesto Cristiano
    Roccarina, Davide
    Novi, Maraluisa
    Ainora, M.
    Garcovich, M.
    Gigante, Giovanni
    Cammarota, Giovanni
    Gasbarrini, Giovanni
    Ghirlanda, Giovanni
    Gasbarrini, Antonio
    [J]. GASTROENTEROLOGY, 2008, 134 (04) : A215 - A215
  • [45] Celiac disease serology in irritable bowel syndrome and dyspepsia: A population-based case-control study
    Locke, GR
    Murray, JA
    Zinsmeister, AR
    Melton, LJ
    Talley, NJ
    [J]. MAYO CLINIC PROCEEDINGS, 2004, 79 (04) : 476 - 482
  • [46] Antibiotic use as a risk factor for irritable bowel syndrome: Results from a nationwide, case-control study
    Staller, Kyle
    Olen, Ola
    Soderling, Jonas
    Roelstraete, Bjorn
    Tornblom, Hans
    Kuo, Braden
    Nguyen, Long H.
    Ludvigsson, Jonas F.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 58 (11-12) : 1175 - 1184
  • [47] Association between dietary inflammatory index (DII) and risk of irritable bowel syndrome: a case-control study
    Eslampour, Elham
    Ghanadi, Koroush
    Aghamohammadi, Vahideh
    Kazemi, Alireza Moayed
    Mohammadi, Rasool
    Vahid, Farhad
    Abbasnezhad, Amir
    [J]. NUTRITION JOURNAL, 2021, 20 (01)
  • [48] SMALL INTESTINAL BACTERIAL OVERGROWTH IN A CHILDREN POPULATION AFFECTED BY IRRITABLE BOWEL SYNDROME: A CASE-CONTROL STUDY
    Scarpellini, E.
    Fundaro, C.
    Giorgio, V.
    Pantanella, A.
    Cesario, V.
    Lauritano, E. C.
    Roccarina, D.
    Novi, M. L.
    Ainora, M. E.
    Garcovich, M.
    Gigante, G.
    Cammarota, G.
    Gasbarrini, G.
    Ghirlanda, G.
    Gasbarrini, A.
    [J]. DIGESTIVE AND LIVER DISEASE, 2008, 40 : S59 - S59
  • [49] Small Intestinal Bacterial Overgrowth in a Children Population Affected By Irritable Bowel Syndrome: A Case-Control Study
    Scarpellini, Emidio
    Fundaro, Carlo
    Giorgio, Valentina
    Gabrielli, Maurizio
    Lauritano, Ernesto Cristiano
    Roccarina, Davide
    Gigante, Giovanni
    Barbaro, Federico
    Rinninella, Emanuele
    Ianiro, Gianluca
    Landolfi, Raffaele
    Gasbarrini, Giovanni
    Gasbarrini, Antonio
    [J]. GASTROENTEROLOGY, 2009, 136 (05) : A370 - A370
  • [50] Inulin, Choline and Silymarin in the Treatment of Irritable Bowel Syndrome with Constipation-Randomized Case-Control Study
    Barboi, Oana-Bogdana
    Chirila, Ioan
    Ciortescu, Irina
    Anton, Carmen
    Drug, Vasile-Liviu
    [J]. JOURNAL OF CLINICAL MEDICINE, 2022, 11 (08)